Furthermore, higher SRXN1 expression levels were observed in squamous patients than in adenocarcinoma patients (P < 0.05, Figure 4K), suggesting that SRXN1 might be correlated with the lung cancer subtype. Here, SRXN1 is linked to lung cancer.